Video Experimental Relacionado
Updated: Jun 11, 2026
12:43
On-Chip Endothelial Inflammatory Phenotyping
Published on: July 21, 2012
La simvastatina previene la hiporeactividad vascular durante la inflamación.
Johannes Pleiner1, Georg Schaller, Friedrich Mittermayer
1Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.
Circulation
|November 3, 2004
Resumen
Las dosis altas de simvastatina impidieron la hiporeactividad vascular durante la endotoxemia. Esta terapia con estatinas preservó la función de los vasos sanguíneos y redujo los marcadores inflamatorios en voluntarios sanos, lo que sugiere efectos vasoprotectores.
Área de la Ciencia:
- Farmacología Cardiovascular Farmacología Cardiovascular
- Inflamación e inmunología.
- La función endotelial es la función endotelial.
Sus antecedentes:
- Las estatinas poseen propiedades antiinflamatorias y antioxidantes más allá de la reducción de lípidos.
- Se observa hiporeactividad vascular a la acetilcolina (ACh) y la norepinefrina (NE) durante la inflamación.
Objetivo del estudio:
- Investigar si la simvastatina puede prevenir la hiporeactividad vascular a ACh y NE durante la inflamación experimental aguda.
Principales métodos:
- Un estudio aleatorizado, controlado con placebo en 20 voluntarios sanos.
- Se midieron las respuestas del flujo sanguíneo del antebrazo (FBF) a NE, ACh y nitroglicerina (NTG).
- La inflamación fue inducida con la endotoxina de Escherichia coli (lipopolisacárido [LPS]).
Principales resultados:
- La administración de LPS redujo las respuestas de FBF a NE (43%) y ACh (48%), pero no a NTG.
- La simvastatina (80 mg) conservó completamente las respuestas de la FBF a la NE y ACh.
- La simvastatina mitigó los aumentos inducidos por LPS en el estallido oxidativo de los neutrófilos y el TNF-alfa.
Conclusiones:
- Las dosis altas de simvastatina muestran potentes efectos vasoprotectores durante la endotoxemia.
- Estos hallazgos sugieren la utilidad de la simvastatina en el manejo de la hiporeactividad vascular en la inflamación sistémica aguda.
Videos de Conceptos Relacionados
01:30Inflammatory Response I: Vascular and Cellular
The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...
01:23Antihypertensive Drugs: Vasodilators
Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:16Vascular Spasm
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last for...
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...